Search Results 251-260 of 17347 for SC
The purpose of this study is to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in ...
The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose combination for subcutaneous ...
Additionally, to assess the safety of daratumumab SC in treating patients with PGNMID by assessing the incidence of major infections, eye complications, and ...
... SC, Habermann EB, Bosch W, Cowart JB, Yao X. Safety in a hybrid hospital-at-home program versus traditional inpatient care: A pragmatic randomized ...
SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...
We have developed a high-resolution genetic screening approach called single-cell CRISPR gene tiling, also known as sc-tiling. This method enables the de ...
The team has developed a recombinant adeno-associated virus (AAV) carrying the IL-1Ra cDNA (sc-rAAV2.5IL-1Ra) as a therapeutic for injection into joints ...
Clark SC, Hanson JA, Lee DR, Spinner RJ, Economopoulos KJ, Hevesi M, Krych AJ. Clinical Outcomes After Proximal Hamstring Repair With Allograft Augmentation ...
... SC, Soares KC, Cooney CM, Eckhauser FE. Ventral hernia repair in patients with abdominal loss of domain: an observational study of one institution's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!